Thursday - June 04, 2026

Treatment-Resistant Depression Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Advancements in Novel Psychedelic-Based Therapies | DelveInsight

The market dynamics for Treatment-Resistant Depression (TRD) are expected to grow significantly due to the rising prevalence of depression, increasing cases unresponsive to standard antidepressants, greater mental health awareness, and advancements in psychedelic-based therapies. Emerging therapies such as COMP360, BPL-003, … Continue reading

Essential Thrombocythemia Market is Expected to Witness Significant Growth by 2034 Due to Rising Disease Burden and Emerging Novel Therapies | DelveInsight

The market dynamics for Essential Thrombocythemia are anticipated to witness notable growth driven by the increasing prevalence of ET, growing awareness regarding myeloproliferative neoplasms, advancements in genetic mutation testing, and increasing focus on preventing thrombotic complications. Additionally, the development of … Continue reading

Xerostomia Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Emerging Novel Therapies | DelveInsight

The market dynamics for Xerostomia are anticipated to witness notable growth driven by the increasing prevalence of xerostomia associated with aging populations, rising polypharmacy use, increasing cases of Sjögren’s syndrome, growing head and neck cancer survivorship, and improved awareness regarding … Continue reading

Basal Cell Carcinoma Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Emerging Novel Therapies | DelveInsight

The market dynamics for Basal Cell Carcinoma (BCC) are anticipated to witness notable growth driven by the increasing incidence of BCC, heightened UV exposure, aging population, growing awareness regarding early diagnosis, and the launch of emerging therapies. Additionally, the development … Continue reading

Food Allergy Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Food Allergy Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Food Allergy pipeline landscape. It covers the Food Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Epidermolysis Bullosa Treatment Pipeline Shows Strong Momentum as 18+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Epidermolysis Bullosa Pipeline Insight, 2026” report provides comprehensive insights about 18+ companies and 22+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the Epidermolysis Bullosa pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Expands as 22+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Cutaneous T-cell lymphoma Pipeline Insight 2026” report provides comprehensive insights about 22+ companies and 25+ pipeline drugs in the Cutaneous T-cell lymphoma pipeline landscape. It covers the Cutaneous T-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Endometrial Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s, “Endometrial Cancer Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Endometrial Cancer pipeline landscape. It covers the Endometrial Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Pancreatic Cancer Clinical Trial Pipeline Gains Momentum: 170+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Pancreatic Cancer Pipeline Insight 2026” report provides comprehensive insights about 170+ companies and 200+ pipeline drugs in Pthe ancreatic Cancer pipeline landscape. It covers the Pancreatic Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading